Harnessing Novel Biology with a Next-Generation E3 Ligase in Targeted Protein Degradation

11:30 am - Thursday 11th June 2026

  • Outlining insights from novel ligase discovery to degrader development
  • Examining the biological differentiation beyond conventional CRBN and VHL E3 ligases
  • Outlining how to enable safer degraders through reduced hematologic toxicity and improved therapeutic index

Speakers:

CEO
Pin Therapeutics